Abstracts will address aspects of liver cancer focusing on all aspects of this disease with a clear emphasis on maximizing focus, exchange, and results.
​​​​​​​All entries should fall under one of the below categories:

​​​​​​​

1. Molecular Pathogenesis, Cell Biology, and Translational Research 

2. Epidemiology, Staging, and Prognosis 

3. Diagnosis, Imaging and Biomarkers

4. Therapy & Miscellaneous

5. Clinical Trials in progress

For Abstract Submitters 

Late-Breaking Abstract Submission

The submission for late-breaking abstracts are now open!
Notification on the outcome of the abstract submission will be sent by email to the submitting author beginning of July 2023.

To submit your abstract, click on the login button. 

If the presenting author is unable to present the late-breaking abstract, one of the co-authors can present in his/her place. An email from the presenting author indicating the change is requested and must be received by the ILCA Office by latest 31 July 2023 (UTC+1). The presenting author or at least one of the abstract co-authors should plan to register and attend the ILCA Annual Conference 2023.

To submit your contribution choose “Submissions”. When creating your submission, please read carefully the ILCA Submission Guidelines.